United Kingdom Genomics Market Insight
Published: 26 May 2026 | Report Format: Electronic (PDF)
The UK genomics market size is rapidly expanding, at about a 15.45% CAGR, and the precision medicine adoption, NHS genome sequencing, AI-powered diagnostics, and biotechnology investments.
UK Genomics Market Insights Forecasts to 2035
- The UK Genomics Market Size Was Estimated at USD 873.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 15.45% from 2025 to 2035
- The UK Genomics Market Size is Expected to Reach USD 3675.2 Million by 2035
Notable Insights for UK Genomics Market
- Whole-genome sequencing constitutes almost 31% of the United Kingdom genomics market, which is facilitated by advancements in oncology diagnostics and genetic diseases, owing to the NHS genomics programs and over $175 million of governmental investments into genomics.
- The cancer genomics accounts for approximately 34% of the United Kingdom genomics market, powered by NHS precision oncology programs, increased uptake of molecular profiling, and £650 million genomics investment programs from the UK government.
- Through Genomics England, more than USD 820 million funding from UK public sources has been raised to enhance genomic databases, speed up precision medicine, intensify rare diseases research, and facilitate innovations in the genomic healthcare under the NHS umbrella.
Download the eBook (ToC)
- More than the 810,000 genomic tests were performed at NHS England in 2024, driving the United Kingdom genomics market via increased oncology diagnostic capabilities, rare diseases screening programs, and personal medicine applications backed by multi-million-pound NHS genomics initiatives.
Why Buy This Report
- Gain deep knowledge about the United Kingdom genomics industry in connection with genome sequencing, precision medicine, molecular diagnostics, and genomic healthcare using artificial intelligence.
- Learn how genomic integration by NHS, genomic cloud technology, innovative bioinformatics, and individualized treatment plans are revolutionizing the healthcare sector in the UK.
- Explore the areas of oncology genomics, genetic testing for newborns, pharmacogenomics, rare diseases diagnostics, and collaboration between the biotech industry and other sectors in the United Kingdom.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the UK genomics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Genomics Market
-
- Illumina
- Oxford Nanopore Technologies
- Thermo Fisher Scientific
- QIAGEN
- Pacific Biosciences
- Genomics England
- Roche
- BGI Genomics
- Others
Recent Developments:
- In May 2026, the United Kingdom genomics market is supported by multi-year £650M+ public investment in Genomics England under Genome UK, advancing NHS precision medicine, genomic databases, and long-term biotechnology and healthcare innovation infrastructure.
- In October 2024, the United Kingdom launched NHS England’s Generation Study with Genomics England, sequencing 100,000 newborns for 200+ conditions, supported by multi-million-pound genomic investments, strengthening precision medicine, healthcare innovation, and long-term genomic infrastructure growth.
Market Segmentation:
United Kingdom Genomics Market, By Technology
- Sequencing
- PCR
- Microarray
- Gene Editing
- Nucleic Acid Extraction & Purification
- Others
United Kingdom Genomics Market, By Application
- Functional Genomics
- Diagnostics
- Biomarker Discovery
- Drug Discovery
- Epigenomics
- Pathway Analysis
- Others
United Kingdom Genomics Market, By End User
- Hospitals & Clinics
- Biotechnology Companies
- Pharmaceutical Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
United Kingdom Genomics Market, By Delivery Mode
- In-House Genomic Testing
- Cloud-Based Genomic Platforms
- Outsourced Genomic Services
Expert Views:
The UK’s genomics market will continue its robust growth trajectory owing to higher rates of genome tests being carried out, increased application of precision medicine, and greater use of next generation sequencing.
Author: Govind and Krishna By Spherical Insights and Consulting